@DiFeoLab
Account based inUnited States
About this account
- Account based in
- United States
- Connected via
- United States App Store
Account-level information from X, not a live location or the device used for a specific post.
Passionate ovarian cancer translational scientist looking to make impactful discoveries and motivate the next generation!
Ann Arbor, MI
Joined February 2013
- Tweets179
- Following813
- Followers521
- Likes1.6K
Analisa DiFeo retweeted
Tremendous opportunity in ovarian cancer early detection. Check it out!
@CCOCR_meeting @OvCaAcademy @NOCCNational @ovarcome @ocrahope @CanaryCenter
🔬 Now Accepting Letters of Intent: The A2C Grant
Tina's Wish is launching a new grant to move ovarian cancer diagnostic biomarkers into clinical trials. $1M over 2 years + expert advisory resources.
LOI Deadline: Sept 9, 2026 tinaswish.org/acceleration-t…
The Fallopian Tube’s Secret Bodyguards 🛡️
I am thrilled to share our lab’s latest study which flips the script on how we think about the origins of ovarian cancer. For a long time, ciliated cells in the fallopian tube were seen as "passive bystanders" in tumor development.
Our research reveals they are actually active guardians of genomic integrity. We found that these cells use a STING-driven surveillance mechanism to act as a biological "cleanup crew," clearing away damaged cells before they can turn into high-grade serous carcinoma (HGSC). When these "gatekeepers" are lost, the door swings wide open for cancer to initiate.
This discovery shifts our understanding of the epithelial microenvironment and points toward new strategies for early prevention.
aacrjournals.org/cancerres/a…
@UMich @UMRogelCancer @CR_AACR @UMichPath
Analisa DiFeo retweeted
Congratulations to Jose Colina, Analisa DiFeo, and colleagues on their simultaneous publication—Ciliated Cells Drive Critical STING-Mediated Tumor Suppression in the Fallopian Tube Epithelium—presented earlier today at #AACR26. Read the article: brnw.ch/21x1Qiw
@Difeolab
Analisa DiFeo retweeted
Excited to share the Ovarian Cancer Research Syndicate line-up for the fall. Please share. We have amazing trainees presenting and the latest from leaders in the field.
@bitlerlabucd @DiFeoLab @WAGO_org @ocrahope @BasserBRCA @TheWistar @airdlab @OvCaAcademy @DNasioudis @achuthz
Analisa DiFeo retweeted
Watch our interview with Analisa DiFeo, PhD, recipient of the 2025 Molecular Cancer Therapeutics Award for Outstanding Journal Article, to learn more about her research: brnw.ch/21wUtYK
@DiFeoLab @umichmedicine @UMichPath @UMRogelCancer
It takes a village, I can truly say I love my job b/c I enjoy the people I work with @ronny_drapkin @delapuente_lab @castro2355_mg @gouthamnarla @UMRogelCancer @UMich @umichmedicine @UMichResearch @umich @LyssiotisLab @uppals @DNagrathLab
A role model in and out of the lab, Dr. Analisa DiFeo (@DiFeoLab) is a first-gen Italian American, a recognized ovarian cancer researcher, and a powerful mentor at #UMichPath. Her journey to cutting-edge translational science is fueled by resilience, purpose, and a deep pride in her roots. Read her story: michmed.org/bQk8r
ALT Portrait of Dr. Analisa DiFeo, Professor of Pathology and ovarian cancer researcher at the University of Michigan, standing at her lab bench. A quote from her is featured on the left: “The reason I went into biomedical research is because I wanted to help patients... You cannot do it alone... If we think we know it all, we lose out. We won’t take that next step or build those relationships.” The image is branded with the hashtag #UMICHPATH.
Analisa DiFeo retweeted
Harini Ram, undergraduate @umichLSA student in the @DiFeoLab, was recently awarded the 2025 Astronaut Scholarship from the @AstroScholarFdn, an award presented to students pursuing a STEM field to conduct research upon completion of their degree.
Ram, the only student from @UMich to receive the award, is currently working on ovarian cancer research where she is studying miR-181a and MYC-mediated metabolic reprogramming in the tumor microenvironments of high-grade serous carcinomas. Her goal is to obtain her medical degree and PhD in a Medical Scientist Training program after graduation. #GoBlue #UMichPath
Read more👉 michmed.org/RBMPy
Analisa DiFeo retweeted
Congratulations to Analisa DiFeo, PhD, and colleagues, recipients of the 2025 Molecular Cancer Therapeutics Award for Outstanding Journal Article. Learn more and read the article: brnw.ch/21wTivI
@DiFeoLab @umichmedicine @UMichPath @UMRogelCancer
Congratulations Grace this is a well-deserved recognition of your hard work, scientific curiosity, and dedication to advancing cancer research. We're especially grateful to the Rogel Cancer Center for their continued investment in young scientists—support like this makes transformative research possible.
Join us in congratulating @MCP_Grad_Prog student Grace McIntyre, winner of the 2025 @UMRogelCancer Center Graduate Student Scholarship!
Grace, a member of the @DiFeoLab, is being recognized for her innovative work targeting microRNA-181a, a key player in cancer growth and immune suppression.
Congratulations, Grace! #UMichPath michmed.org/XWWGm
Feeling incredibly honored and deeply grateful to MCT for this recognition, and to all my amazing collaborators and co-authors who made this work possible. Congratulations to @DiFeoLab @umichmedicine @UMichPath @UMRogelCancer
Learn more: brnw.ch/21wSfdk
#AACR25
Congratulations to Analisa DiFeo, PhD, and colleagues, recipients of the 2025 Molecular Cancer Therapeutics Award for Outstanding Journal Article. Learn more: brnw.ch/21wSfdk
#AACR25 @DiFeoLab @umichmedicine @UMichPath @UMRogelCancer @AACR
Analisa DiFeo retweeted
Congratulations to Analisa DiFeo, PhD, and colleagues, recipients of the 2025 Molecular Cancer Therapeutics Award for Outstanding Journal Article. Learn more: brnw.ch/21wSfdk
#AACR25 @DiFeoLab @umichmedicine @UMichPath @UMRogelCancer @AACR
Analisa DiFeo retweeted
📢JOIN US LIVE Wednesday, April 9, 4 PM ET! We're co-hosting the @RNASociety RNA Collaborative Seminar Series with @UR_Med, featuring talks by Ph.D. candidate Grace McIntyre @DiFeoLab and @NilsWalterLab Senior Scientist @AdrienChauvier Zoom registration 👉us02web.zoom.us/webinar/regi…
Learn about the collaborative research happening in our lab to discover innovative RNA therapies for cancer.@UMRogelCancer @UMichPath
📢EXCITED TO ANNOUNCE: RNA Translated 2025 magazine published in wide release! The Power of Collaborative RNA Science. Featuring latest findings from researchers and clinicians in RNA science and medicine at @UMich. Read the full story👉 rna.umich.edu/rna-translated… @RNASociety #RNA
Congratulations Dr. Puleo @Noah_Puleo on successfully defending your PhD thesis. It was a pleasure mentoring you and seeing you evolve into an accomplished scientist and leader. Good luck on your next endeavor and I’m excited to see your many future successes.
Read our latest review on miR-181a, the oncogenic miRNA shaping tumor pathways and immune defenses. Uncover its potential to revolutionize precision medicine and RNA therapeutics! #RNAtherapeutics #noncodingRNAs
tandfonline.com/doi/full/10.…
Small but mighty…excited for the future of miRNA in cancer and therapeutics!@umichrna thanks for highlighting my thoughts on the impact of this years Nobel Price!
🏅 From AI to gene regulation: Nobel-winning discoveries show RNA’s far-reaching influence
📢+ @DiFeoLab faculty perspective on miRNA @umichmedicine
👏Illustration courtesy @NobelPrize Ill. Niklas Elmehed ©Nobel Prize Outreach
Read the full story 👇
rna.umich.edu/rna-science-fr…
PP2A emerges as a master regulator of the integrated stress response pathway, controlling TFE3, ATF4, & CHOP. Paving the way for PP2A-modulating drugs that selectively target cancer cells. Big potential for safer cancer treatments!
nature.com/articles/s41418-0…
What a group of passionate, intelligent, and dedicated scientists!! #cancerbio @UMRogelCancer @umichmedicine
Group shot from our Graduate Program in Cancer Biology 😃 Such a pleasure working with this awesome group! #GoBlue 〽️💙💛
